
[ Tue, Nov 07th 2017 ]: WOPRAI
[ Tue, Nov 07th 2017 ]: WOPRAI
[ Tue, Nov 07th 2017 ]: WOPRAI
[ Tue, Nov 07th 2017 ]: WOPRAI
[ Tue, Nov 07th 2017 ]: WOPRAI
[ Tue, Nov 07th 2017 ]: WOPRAI
[ Tue, Nov 07th 2017 ]: WOPRAI
[ Tue, Nov 07th 2017 ]: WOPRAI

[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI

[ Fri, Nov 03rd 2017 ]: WOPRAI
[ Fri, Nov 03rd 2017 ]: WOPRAI
[ Fri, Nov 03rd 2017 ]: WOPRAI
[ Fri, Nov 03rd 2017 ]: WOPRAI
[ Fri, Nov 03rd 2017 ]: WOPRAI
[ Fri, Nov 03rd 2017 ]: WOPRAI
[ Fri, Nov 03rd 2017 ]: WOPRAI
[ Fri, Nov 03rd 2017 ]: WOPRAI
Vamil Divan Maintained (TEVA) at Sell with Decreased Target to $8 on, Nov 6th, 2017


🞛 This publication is a summary or evaluation of another publication
Vamil Divan of Credit Suisse, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Sell with Decreased Target from $14 to $8 on, Nov 6th, 2017.
Vamil has made no other calls on TEVA in the last 4 months.
There are 9 other peers that have a rating on TEVA. Out of the 9 peers that are also analyzing TEVA, 6 agree with Vamil's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Gregg Gilbert of "Deutsche Bank" Downgraded from Strong Buy to Hold on, Friday, November 3rd, 2017
- Douglas Tsao of "Barclays" Maintained at Hold with Decreased Target to $19 on, Friday, October 20th, 2017
- Liav Abraham of "Citigroup" Downgraded from Strong Buy to Hold on, Wednesday, August 16th, 2017
- Tyler Van Buren of "Cowen & Co." Downgraded from Buy to Hold on, Friday, August 4th, 2017
- Aaron Gal of "Bernstein" Downgraded from Buy to Hold on, Friday, August 4th, 2017
- Derek Archila of "Oppenheimer" Downgraded from Buy to Hold on, Thursday, August 3rd, 2017
These are the ratings of the 3 analyists that currently disagree with Vamil
- David Risinger of "Morgan Stanley" Maintained at Sell with Decreased Target to $7 on, Friday, November 3rd, 2017
- Tim Chiang of "BTIG" Upgraded from Hold to Strong Buy and Held Target at $24 on, Monday, September 11th, 2017
- Randall Stanicky of "RBC Capital" Downgraded from Buy to Sell on, Friday, August 4th, 2017
Similar Stocks and Investing Publications
[ Fri, Nov 03rd 2017 ]: WOPRAI
[ Fri, Nov 03rd 2017 ]: WOPRAI
[ Fri, Oct 20th 2017 ]: WOPRAI
[ Thu, Oct 05th 2017 ]: WOPRAI
[ Wed, Oct 04th 2017 ]: WOPRAI
[ Mon, Sep 11th 2017 ]: WOPRAI
[ Wed, Sep 06th 2017 ]: WOPRAI
[ Thu, Aug 24th 2017 ]: WOPRAI
[ Wed, Aug 16th 2017 ]: WOPRAI
[ Mon, Aug 07th 2017 ]: WOPRAI
[ Mon, Aug 07th 2017 ]: WOPRAI
[ Wed, Nov 16th 2016 ]: WOPRAI